Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glenn J Hanna, M.D.

Concepts (240)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms1620244915.860 Why?
Head and Neck Neoplasms30202428945.240 Why?
Carcinoma, Adenoid Cystic920242625.180 Why?
Papillomavirus Infections17202416123.620 Why?
Carcinoma, Squamous Cell22202440212.900 Why?
Salivary Gland Neoplasms520243042.570 Why?
Mouth Neoplasms1020245962.360 Why?
Papillomaviridae13202411172.260 Why?
DNA, Viral7202421942.180 Why?
Neoplasm Recurrence, Local20202492771.780 Why?
Saliva220198280.870 Why?
Skin Neoplasms9202458110.870 Why?
Neoadjuvant Therapy7202428270.850 Why?
Precancerous Conditions320249820.790 Why?
Leukoplakia, Oral42024770.790 Why?
Tumor Microenvironment6202438680.730 Why?
Sjogren's Syndrome120212370.660 Why?
Class I Phosphatidylinositol 3-Kinases420238990.650 Why?
Immunotherapy10202446420.640 Why?
Antineoplastic Agents82023136350.620 Why?
Proto-Oncogene Proteins c-bcl-6120191910.620 Why?
Tretinoin120215190.610 Why?
Chromosomes, Human, Pair 3120193220.600 Why?
Genomics6202058220.550 Why?
Carcinoma, Merkel Cell420223280.550 Why?
Quinolones120203780.550 Why?
Aged, 80 and over262024589190.510 Why?
Antineoplastic Combined Chemotherapy Protocols72023117350.490 Why?
Middle Aged4420242206030.490 Why?
Aged3920241690920.480 Why?
Humans9220247607400.470 Why?
Prognosis132024296010.460 Why?
Iodine Radioisotopes1201810310.460 Why?
Phosphatidylinositol 3-Kinases4202128630.450 Why?
Carcinoma, Neuroendocrine120183390.450 Why?
Genes, Tumor Suppressor1201810560.440 Why?
Kidney Transplantation3202442180.440 Why?
Immunotherapy, Adoptive1202314670.430 Why?
Proto-Oncogene Proteins p21(ras)2202317450.430 Why?
Immunophenotyping2201718640.420 Why?
Neoplasm Metastasis7202449100.400 Why?
Hematologic Neoplasms1202318960.380 Why?
Hypopharyngeal Neoplasms12011510.380 Why?
Residence Characteristics1202120920.370 Why?
Male4220243604020.360 Why?
Adult2920242209950.360 Why?
Neoplasms82023221310.360 Why?
Solitary Fibrous Tumors12011670.360 Why?
Survival Analysis62020100720.350 Why?
Female4320243922030.330 Why?
Retrospective Studies242024805830.330 Why?
CD8-Positive T-Lymphocytes3202345700.330 Why?
Alphapapillomavirus220222180.330 Why?
Hemangiosarcoma120112150.310 Why?
Breast Diseases120114430.290 Why?
Survivors1201823730.290 Why?
Thyroid Neoplasms2201823320.280 Why?
Drug Resistance, Neoplasm3201853040.260 Why?
Treatment Outcome122024645720.260 Why?
Hematoma120117620.260 Why?
Antibodies, Viral1201731490.250 Why?
DNA-Binding Proteins2201995860.240 Why?
Human papillomavirus 16220232670.230 Why?
High-Throughput Nucleotide Sequencing4202036340.220 Why?
Mutation102024300150.220 Why?
Brain Neoplasms1202490260.210 Why?
Adrenal Cortex Hormones2202418780.210 Why?
Receptor, Notch1220244960.210 Why?
Protein-Arginine N-Methyltransferases120231290.210 Why?
Neoplasm Staging62024111180.210 Why?
Vascular Endothelial Growth Factor A2202334920.200 Why?
Oncogene Proteins, Viral120233400.190 Why?
Transcription Factors32022121160.190 Why?
Genetic Predisposition to Disease22024178780.190 Why?
Vascular Endothelial Growth Factor Receptor-2120235460.180 Why?
Cohort Studies72024414640.180 Why?
Neoplasms, Second Primary2202310510.180 Why?
Hospitalization12020107080.180 Why?
Prospective Studies102024543640.180 Why?
Anus Neoplasms120243290.170 Why?
Hematopoietic Stem Cell Transplantation1201856710.170 Why?
Gene Expression Regulation, Neoplastic3202485420.160 Why?
Tumor Burden3202118920.160 Why?
Keratosis12019790.160 Why?
Lip120201970.160 Why?
Patient Selection2202342370.160 Why?
Breast Neoplasms22020209880.160 Why?
Proto-Oncogene Proteins c-myc120249880.160 Why?
Neoplasm Proteins3201836070.150 Why?
Disease Progression42023134950.150 Why?
Gene Expression Profiling3202494170.150 Why?
Combined Modality Therapy4202385160.150 Why?
Prostatic Neoplasms12020111070.140 Why?
Chloride Channels120182210.140 Why?
Tumor Virus Infections120204350.140 Why?
Osteoradionecrosis12017510.140 Why?
Microsatellite Repeats120187830.130 Why?
Frameshift Mutation120183920.130 Why?
Hyperbaric Oxygenation120171650.130 Why?
Radiotherapy, Intensity-Modulated120228010.130 Why?
Young Adult72023591910.120 Why?
DNA3202471960.120 Why?
Polymerase Chain Reaction1202460740.120 Why?
Salvage Therapy1202112630.120 Why?
Oncogenes1202012200.120 Why?
Otorhinolaryngologic Surgical Procedures120183240.120 Why?
Clinical Trials as Topic2202379950.120 Why?
Oncogene Proteins120187180.120 Why?
Societies, Medical2202339010.110 Why?
Gene Dosage1201812170.110 Why?
Disease-Free Survival2202168070.110 Why?
TOR Serine-Threonine Kinases3202320570.110 Why?
Geriatric Assessment1202014110.100 Why?
Urban Population1202020340.100 Why?
Drug Synergism1201617560.100 Why?
Interferon-gamma1202031450.100 Why?
Myringoplasty12011120.100 Why?
Radiosurgery1202113390.090 Why?
Androgen Antagonists1202014090.090 Why?
Nuclear Proteins3202357890.090 Why?
Carcinoma1202223280.090 Why?
Survival Rate32023127190.090 Why?
Molecular Targeted Therapy2202028120.090 Why?
Middle Ear Ventilation120111010.090 Why?
DNA Copy Number Variations1201920200.090 Why?
Lymphatic Metastasis2201529130.090 Why?
Rural Population1202022770.090 Why?
Radiotherapy Dosage3202228970.080 Why?
United States52024722920.080 Why?
Receptor, erbB-21202025530.080 Why?
DNA Mutational Analysis1201841100.080 Why?
Medical Oncology1202023170.080 Why?
Feasibility Studies1201952390.080 Why?
Sirolimus1201415330.070 Why?
Predictive Value of Tests12023152500.070 Why?
Sarcoma1201818000.070 Why?
Graft Rejection1202044380.070 Why?
Genome, Human1202044210.070 Why?
Neoplasms, Radiation-Induced120115490.070 Why?
Incidence32020213390.070 Why?
Biopsy1201867630.060 Why?
Pilot Projects1201986190.060 Why?
Comorbidity12020105070.060 Why?
T-Lymphocytes12023101750.060 Why?
SEER Program2202014500.060 Why?
Tumor Suppressor Proteins1201428030.060 Why?
Logistic Models12019132480.060 Why?
Ifosfamide120232320.050 Why?
Carcinoma, Ductal, Breast1201110840.050 Why?
Lipid A12022700.050 Why?
Radiotherapy Planning, Computer-Assisted2202216550.050 Why?
Oncogene Proteins, Fusion2202216080.050 Why?
Cross-Sectional Studies12022260650.050 Why?
Parotid Gland120221750.050 Why?
Organs at Risk120223590.040 Why?
Histone Demethylases120223230.040 Why?
Kaplan-Meier Estimate2202064730.040 Why?
Cell Cycle Proteins2202234470.040 Why?
Education, Medical, Graduate1201123730.040 Why?
Toll-Like Receptor 4120225780.040 Why?
Quality of Life12020133590.040 Why?
Methylprednisolone120203850.040 Why?
Cell Transformation, Viral120205260.040 Why?
Signal Transduction22018234150.040 Why?
Hypokalemia120191530.040 Why?
Mucositis120191080.040 Why?
Clinical Trials, Phase II as Topic120206290.040 Why?
Virus Integration120203040.040 Why?
Jaw12017930.030 Why?
Time-Lapse Imaging120171940.030 Why?
Maximum Tolerated Dose120198830.030 Why?
raf Kinases120161180.030 Why?
Genome, Viral120206650.030 Why?
Workflow120218490.030 Why?
Spheroids, Cellular120173290.030 Why?
Prednisone1202015620.030 Why?
Clinical Competence1201147900.030 Why?
Diagnosis, Differential12011129660.030 Why?
Sex Distribution1202022780.030 Why?
Radiotherapy, Adjuvant1202017840.030 Why?
Cytokines2202273730.030 Why?
Follow-Up Studies12017390620.030 Why?
MAP Kinase Kinase Kinases120162540.030 Why?
Sensitivity and Specificity22020146490.030 Why?
Age Distribution1202028720.030 Why?
Receptor, Notch212015870.030 Why?
ras GTPase-Activating Proteins12015940.030 Why?
Lymphocytes, Tumor-Infiltrating1202010880.030 Why?
Cisplatin1202016500.030 Why?
Adolescent22023882470.030 Why?
Postoperative Period1201918120.030 Why?
Quality-Adjusted Life Years1202017230.030 Why?
Age of Onset1202033030.030 Why?
Radiation Dosage1202219560.030 Why?
Gene Rearrangement1201811250.030 Why?
Genetic Heterogeneity120167330.030 Why?
Immunity120189940.030 Why?
Diarrhea1201913170.030 Why?
In Situ Hybridization, Fluorescence1201825090.030 Why?
Phylogeny1202028050.030 Why?
Immunologic Factors1202115890.020 Why?
Analysis of Variance1202062230.020 Why?
Income1202018700.020 Why?
Chemotherapy, Adjuvant1202035140.020 Why?
Cyclin-Dependent Kinase Inhibitor p16120156970.020 Why?
Lymph Nodes1202334610.020 Why?
Microfluidic Analytical Techniques120177990.020 Why?
Drug Administration Schedule1201948450.020 Why?
Cell Line, Tumor22017169680.020 Why?
Cell Culture Techniques1201716620.020 Why?
Tumor Cells, Cultured1201761260.020 Why?
Killer Cells, Natural1201821910.020 Why?
Models, Educational120113730.020 Why?
Tomography, X-Ray Computed22023205560.020 Why?
Recurrence1202084260.020 Why?
Computational Biology1202035090.020 Why?
Flow Cytometry1201758630.020 Why?
Protein Conformation1201439650.020 Why?
Proto-Oncogene Proteins B-raf1201620570.020 Why?
Antibodies, Monoclonal1202291710.020 Why?
Statistics, Nonparametric1201128510.020 Why?
Genotype12020129770.020 Why?
Reproducibility of Results12023200770.010 Why?
Longitudinal Studies12020145990.010 Why?
Tumor Suppressor Protein p531201529160.010 Why?
Educational Measurement1201112520.010 Why?
Case-Control Studies12022221530.010 Why?
Immunohistochemistry12017110690.010 Why?
Smoking1202090540.010 Why?
Sequence Analysis, DNA1201547390.010 Why?
Base Sequence12015124200.010 Why?
Radiography1201469610.010 Why?
Practice Guidelines as Topic1202073900.010 Why?
Magnetic Resonance Imaging22021364010.010 Why?
Polymorphism, Single Nucleotide12020159080.010 Why?
Lung Neoplasms12023133830.010 Why?
Child12023800890.010 Why?
Internship and Residency1201158780.010 Why?
Mice12017813680.010 Why?
Animals120171682020.000 Why?
Hanna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (240)
Explore
_
Co-Authors (164)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.